June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
The clinical spectrum of peripapillary intraretinal fluid unrelated to pachychoroid or neovascular disease
Author Affiliations & Notes
  • Marc Sirks
    Ophthalmology, Amsterdam UMC Locatie AMC, Amsterdam, North Holland, Netherlands
  • Elon van Dijk
    Ophthalmology, Leids Universitair Medisch Centrum, Leiden, Zuid-Holland, Netherlands
  • Laurenz Pauleikhoff
    Ophthalmology, Amsterdam UMC Locatie AMC, Amsterdam, North Holland, Netherlands
    Ophthalmology, Universitatsklinikum Freiburg, Freiburg, Baden-Württemberg, Germany
  • Rosalie Diederen
    Ophthalmology, Amsterdam UMC Locatie AMC, Amsterdam, North Holland, Netherlands
  • Camiel J.F. Boon
    Ophthalmology, Amsterdam UMC Locatie AMC, Amsterdam, North Holland, Netherlands
    Ophthalmology, Leids Universitair Medisch Centrum, Leiden, Zuid-Holland, Netherlands
  • Footnotes
    Commercial Relationships   Marc Sirks None; Elon van Dijk None; Laurenz Pauleikhoff None; Rosalie Diederen None; Camiel Boon None
  • Footnotes
    Support  This research was funded by Stichting Blindenhulp, Mathilde Grant, Stichting Leids Oogheel-kundig Ondersteuningsfonds, Rotterdamse Stichting Blindenbelangen, Stichting Ooglijders, Stichting tot Verbetering van het Lot der Blinden, and the Netherlands Organisation for Scienti-fic Research (NWO). The funding organizations Macula Fonds, Retina Nederland Onderzoek Fonds, Landelijke Stichting voor Blinden en Slechtzienden, Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, and Stichting Blinden-Penning contributed through UitZicht.
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 5407. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Marc Sirks, Elon van Dijk, Laurenz Pauleikhoff, Rosalie Diederen, Camiel J.F. Boon; The clinical spectrum of peripapillary intraretinal fluid unrelated to pachychoroid or neovascular disease. Invest. Ophthalmol. Vis. Sci. 2023;64(8):5407.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To discuss the differential diagnosis in patients with peripapillary intraretinal fluid without signs of pachychoroid or neovascular disease on multimodal imaging.

Methods : The charts and multimodal imaging of consecutive patients with peripapillary intraretinal fluid were assessed retrospectively. All patients that had any signs of pachychoroid disease (thickened choroid on optical coherence tomography (OCT), choroidal hyperpermeability on indocyanine green angiography (ICGA), or choroidal pachyvessels on any imaging modality) were excluded. All patients that showed any signs of neovascularization (on OCT or fluorescence angiography (FA)) were excluded. All patients without pachychoroid or neovascular disease were reviewed by two senior retina specialists, who classified these patients based on clinical characteristics on multimodal imaging including OCT, fundus autofluorescence, FA, and ICGA.

Results : A total of 60 patients with peripapillary fluid were assessed, of which 8 cases were included in this study. The average age of these patients was 64 years (range 42-79), and 3 out of 8 cases were female. Seven out of 8 cases showed unilateral peripapillary intraretinal fluid. A broad spectrum of anomalies were visible, and although the cause of the fluid was not always fully certain, the most probable diagnoses found were optic disk pit (2 cases), stellate non-hereditary idiopathic foveomacular retinoschisis (1 case), vitreomacular traction (1 case), myopia-associated maculopathy (1 case), morning glory (1 case), and of unknown cause (2 cases).

Conclusions : This case series shows that the presence of peripapillary intraretinal fluid without signs of pachychoroid or neovascular disease is associated with a broad spectrum of differential diagnoses. It is important to establish the correct diagnosis, so that the appropriate treatment may be chosen.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×